Fri, March 31, 2023

Jason McCarthy Maintained (BCLI) at Strong Buy with Increased Target to $150 on, Mar 31st, 2023

Jason McCarthy of Maxim Group, Maintained "Brainstorm Cell Therapeutics Inc." (BCLI) at Strong Buy with Increased Target from $75 to $150 on, Mar 31st, 2023.

Jason, nor any peers, have made any analyst calls on BCLI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30